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The logistics system in the management of essential and generic medicines (MEGs) is the fundamental point to 
provide quality health care to the population, in order to ensure the sustainability of integrated health center 
(ISC) activities. The purpose of this work was to assess the performance of the ITC logistics system of 
Brazzaville by analyzing the different indicators. This study was a retrospective and observational study. The 
strategy consisted of conducting a survey among a sample of 17 CSIs in the seven districts of the city of 
Brazzaville. Data were collected over a three-month period following a one-on-one interview with Drug 
Management Officers, Document Operations, and Drug Availability Observation in CSI pharmacies. These data 
were recorded on a survey sheet, and an observation grid was established. 
The analysis of logistic system variables revealed that: drug selection was fair in 76.5% of CSI and satisfactory 
in 23.5%. Quantification was good in 17.6% of cases, fair in 58.8%, and unsatisfactory in 23.5%. Storage 
conditions were fair in 41.2% and unsatisfactory in 29.4%. Distribution is unsatisfactory in the majority of CSIs. 
76.46% of CSIs have unsatisfactory management tools. Drug use is fair at 47% with low availability of drugs. 
The study found that  the improvement of MEG availability is related to the organization of the management 
circuit and the logistics system. 
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Medicines essential, constitutes a specific commercial element whose distribution is influenced by the level of 
the economy and development of the countries [1]. In Alma Ata in 1978, the World Health Organization (WHO) 
championed the concept of essential drugs as an integral part of national health policies [2,3] and made access to 
essential drugs the eighth component of Primary Health Care (PHC) [3]. For many countries, the arrival of the 
Bamako Initiative was an essential strategy to offer low-cost quality care and ensure the sustainability of 
activities at the level of Integrated Health Centers. (CSI) [4,5]. In Africa, this has translated into the field 
through the establishment of generic generic medicine (MEG) purchasing centers and drug depots in health 
facilities; this is the case in Congo where the main supply center, called the Congolaise of Essential and Generic 
Medicines (COMEG) was created in 2006 [6]. However, the management of essential drugs remains a problem. 
In Congo, the Ministry of Health has shown that the availability of drugs is 60% in public health facilities, 
53.3% in the central supply [7]. The purpose of our work is to appreciate the performance logistics system by 
analyzing the different indicators. 
2. Material and methods 
It was a retrospective and observational study from March 20 to June 25, 2013, a period of 3 months. The study 
was carried out in the CSIs of the seven health and social districts (CSS) distributed in the seven districts of the 
city of Brazzaville: Makelekele (Diata, Jean Taty, Terynkio), Bacongo (Bissita, Madame), Poto-Poto ( Q34, 
Martyrs, Q32), Moungali (Plateaux, Moukondo), Ouenzé (Jane Vialle, Q58, Ex-Adventist), Talangai (Congo 
River, Marien NGOUABI, Intendance) and M'Filou (Indzouli, Kibouende-M'Filou). The target population 
consisted of the managers responsible for the management of MEGs in the CSIs and all the pharmacies of the 
CSIs. Random sampling for both targets was performed. The sampling techniques consisted of the reasoned 
choice of agents responsible for MEG management and enumeration for pharmacies. The sample size was after 
counting and reasoned choice, with at least two CSIs per CSS. The data was collected after an individual 
interview with drug management officers, document processing and observation of drug disposition in 
pharmacies. Then, recorded in a personal interview guide, counting cards and an observation grid. These 
elements were initially tested in the field at CSI Intendance. After that, modifications were made following the 
difficulties encountered. 
The variables studied were: 
• General characteristics of CSI: type of minimum activity package of CSI (standard and expanded); 
• General characteristics of the officers responsible for the management of MEGs: gender, qualification 
(which corresponds to academic training), seniority at the post, and training (skills passed on in the 
management of MEGs); 
o Selection: availability and use of the national list of essential medicines, assessment of selection 
(satisfactory, fair, unsatisfactory); 
o Quantification: availability and use of standard MEG control media, quantification assessment 
(satisfactory, fair, unsatisfactory); 




o Transport acquisition: assessment of the transport acquisition (satisfactory, fair, unsatisfactory). 
o Storage: 
o Rack type: alphabetical, therapeutic group, without order; 
o Cleaning the room and shelves; 
o Storage conditions: visible identification labels, secure premises, existing cold chain, materials and 
arrangement of shelves, sufficient space, ventilation, ... 
o Stock tools: stock card, purchase order / delivery; 
• Assessment of storage (satisfactory, fair, unsatisfactory). 
• Distribution: execution of a CSI command by the CSS. 
• Use of MEGs: standard treatments, pricing of treatment and assessment of MEG use (satisfactory, fair, 
unsatisfactory). 
• Maintenance of management tools: satisfactory, fair, unsatisfactory. 
• Availability of MEGs: Main MEGs, Assessment of MEG availability (satisfactory, fair, 
unsatisfactory); 
• Logistics system: elements of the system and appreciation. 
• At the end of the data collection, the cards were manually scanned. Quantitative variables are expressed 
as mean and median. Excel 2013 software was used for statistical analysis. 
• Operational definitions: 
o Logistics system: physical circuit of the drug. Set of administrative procedures for the management of 
information, resources, means of transport, and storage facility premises set up to enable the client to 
obtain quality and sufficient quantity of drugs. 
o Selection: choice of a drug at the time of expression of needs at the level of the health facility. 
o Quantification: determination of the quantity of drugs to order. 
o Acquisition-Transport: process including purchases, transportation and receipt of drugs at the sales 
depot. It starts from the placing of the order to the entry into stock of the drug. 
o Distribution: transfer of drugs from a higher center to a lower level. 
o Minimum Activity Package (MAP): curative (acute episode, chronic disease) and preventive (prenatal 
consultations, family planning, vaccination, preschool care) consultations. 
 Expanded LDCs: CSI performing deliveries 
 Standard PMA: no practice of childbirth 
3. Results 
3.1. General characteristics of CSIs and agents  
In our study, fifteen CSIs had a minimum standard activity package of 88.2% and two expanded activity 
packages were 11.8%. 
 In CSI workers, women accounted for 58.8% and men were 41.2%. A female predominance with a sex ratio: 
1.3. 
 Of the thirty-four CSI staff, 76.5% of MEG managers had received training related to their task while 23.5% of 




officers had none. 
• Qualification 
Table 1: Distribution of MEG Management Officers by Qualification 
Qualification  Effectif  % 
Technicien supérieur en pharmacie 16 47,05 
Assistant sanitaire général 











Several profiles were found during the study. However, the qualification of senior technicians in pharmacy was 
represented at 47% (Table I). 
• Seniority 
Table 2: Distribution of MEG Management Officers by Seniority in Years 
Seniority in Years Effectif  % 













  5,88 
11,76 
100 
The most represented seniority bracket was 0-5 (Table II). 
Selection 
• Availability and Use of the National List of Essential and Generic Medicines (AUNME) 
Of the 17 CSIs, the LNME was only available in seven CSIs, ie 41.2%. Of these, it was only used in three CSIs, 
ie 42.85% of the 41.17% available. This method of selection was passable in 76.74% of cases, n = 13, and in 
23.53% of cases it was unsatisfactory. 
3.2. Quantification 
• Availability and use of standard MEG command media 




Sixteen CSIs had standard MEG control media at 94.11%. However only three CSIs are 17.64% of the 16 used 
these media to place orders. 
4. Storage 
MEG rack type                       
The study reveals that in more than half of the cases (58.6%), shelving in all CSIs did not have a particular order 
of disposition. Therapy group shelving was done in 35.3% of CSIs while alphabetical shelving was used very 
little (5.9%). 
Cleaning the room and shelves 
In 88.2% that is fifteen CSI, the rate of cleaning of the storage room was daily and weekly in two CSI is 11.8%. 
Floor cleaning has not been done every day in any CSI. It was weekly in thirteen CSI (76.5%) and monthly in 
four (23.5%) CSI. 
Storage conditions  
Table 3: Distribution of CSIs according to storage conditions 
Items  Yes   No   
Products arranged in such a way that the identification labels are visible 
The packaging is in good condition 
Products stored in PPPS 
Products protected from heat 
Products protected from light 
Products protected from water and moisture 
Damaged and expired products separated from the vouchers 
Insect and rodent free products 
Secure premises 
Existing cold chain 
Material of adapted shelves 
Sufficient space 
Products stored at least 10 cm above the floor 
Products at least 30 cm from walls and batteries 
Products stored on a height of 2.5 m minimum 
Accessible firefighting equipment 
Products arranged separately from insecticides and other products 





































• Stock tools 
In all the CSIs surveyed during the study, stock sheets and purchase orders were found. However only 29.4% of 
CSIs used stock cards and 41.1% purchase orders. 
5. Distribution 
CSS do not have a vehicle for the delivery of medicines. Centers that have placed orders are the only ones 




responsible for transporting these drugs on delivery. 
6. Logistics system  
Table 4: Summary of logistic system components and their assessments 
Components of the logistic 
system  
Score Appreciation 





Fair in 10 CSIs are 58.83% / Satisfactory in 4 CSIs are 25.52% / 
Unsatisfactory in 3 CSIs are 17.6% 
• .Acquisition / 
Transport 
1 Average in 7 CSI is 41.17% / satisfactory in 10 CSI is 58.83% 




Not satisfactory in 5 CSI is 29.41% / Passable in 7CSI is 41.17% / 
Satisfactory in 5 CSI is 29.41% 





Average in 8CSI is 47.05% / Satisfactory in 7 CSI is 41.17% / 
Unsatisfactory in 2 CSI is 11.76% 




Not satisfactory in 8CSI is 47.05% / satisfactory in 7 CSI is 41.17% / 
passable in 2 CSI or 11.74% 




Fair in 7 CSIs are 41.17% / Satisfactory in 4 CSIs are 23.52% / 
Unsatisfactory in 6 CSIs are 35.29% 
• Logistics system 
 
5 Unsatisfactory in the 17 CSIs 
 
7. Discussion  
Our study included the public and private non-profit health centers of the Brazzaville department as well as 
those responsible for the management of MEGs to guarantee representativeness. The investigation revealed that 
the staff was qualified. She highlighted several qualifications with senior pharmacy technicians who accounted 
for 47%. These results are better than those observed in the Comoros during the evaluation of the 
pharmaceutical sector in 2003 which had found 89% of sellers in pharmacies without qualification [8]. 
The selection variable obtained a score of 01 and according to our evaluation criteria, it is passable. The main 
problem is in the availability of the National Essential Medicines List (NEML) and its use. Of the 07 CSIs that 
had the LNME, only 03 CSI used it when ordering. In CSIs that did not have the LNME, MEG management 
agents reported referring to previous monthly consumption and epidemiological profile at the time of placing 
orders, which favors the selection of specialty drugs with a impact on the cost of care. These results are 
consistent with those of Nkogho in Gabon, who showed a high tendency for the prescription of specialties to the 
detriment of MEGs. This was partly due to the lack of dissemination of the LNME [9]. 
The quantification variable did not obtain a satisfactory score. In fact, 16 CSIs had standard MEG command 
supports that were not always complete. The heads of the center and the agents in charge of the inventory 




management determined after the inventory the quantities of the monthly order. These orders are intended to 
cover the next month, but it was not uncommon to see emergency orders launched during the months. This is in 
line with WHO's 2004 findings, which states that it is still difficult for some populations to ensure a regular 
supply as needs are poorly estimated, leading to many ruptures and expiry [10]. Also, the multiple stockouts in 
all CSIs were not only caused by MEG shortages at the COMEG or SSC level, but also the consequence of poor 
quantification methods. Although 76.47% of MEG management staff were trained in MEG management, the 
application of formulas for determining quantities to order was almost non-existent. This is comparable to the 
results of Nkunzimana in 1996, which noted in its study on the availability of MEGs in the Atlantic this lack of 
control of procedures by stock managers [11]. The transport acquisition variable is passable because it has a 
score of 7. The problems at this level lie in the delivery times which vary from one week to one month, with 
quantities not always satisfactory. These results are similar to the evaluation carried out in Burkina Faso by the 
Ministry of Health, which reveals the non-respect of procurement deadlines [12]. The storage variable got a 
score of 28 for all CSIs and therefore unsatisfactory. In each CSI, there are two types of inventory: "large stock" 
managed by the center's drug management agents and another "retail store" managed by sales clerks. In the big 
stock, the drugs are arranged on the shelves. The material of the shelves is far from satisfactory to ensure good 
storage conditions. In 12 CSI MEGs are stored in cabinets, hermetically sealed. The drugs are poorly ventilated, 
because these cabinets do not offer enough space. These results are in agreement with those of Moore G. in Mali 
who noted the same shortcomings in the storage conditions [13]. Only 05 CSI hold acceptable conditions with 
good shelf material, preferably wooden shelves and the premises of the 17 CSI, are secured. Boussengar in 
Morocco, had noted acceptable storage conditions where the products are well ranked [14] .The measures that 
managers took to ensure the quality of MEG during storage are the expiry date, in which case they have claimed 
to store the MEGs according to First Ever Outdated (PPPS) justifying the absence of obsolete MEGs throughout 
the survey period, except drugs donated by the CSS. The distribution variable is unsatisfactory because it 
remains a problem for many African countries. The Ministry of Health in the Congo, says that there is no 
organized system of drug distribution [15]. Just as a study conducted in the Democratic Republic of Congo [16] 
has shown. There are no vehicles to ensure the distribution of MEGs, in contrast to the shortage of vehicles 
observed by Somda C. in Benin [17] and Boussengar in his study on the analysis of the management of medical 
devices [14]. The variable score using MEG is 12, so passable. However, 05 CSIs had satisfactory use of MEGs, 
08 CSIs and then 04 others were respectively rated fair and unsatisfactory. Eleven CSIs had a flowchart. There 
are therefore standard schemes of treatment in these CSIs; but among the CSIs with standard treatments, only 03 
CSIs placed their orders taking these into account. In the 06 CSIs where we did not find a flow chart, managers 
reported using their experience in treating certain diseases. Drugs delivered with or without a chart pose the 
problem of the rational use of MEGs, as Somda found in Benin in 2006 [17]. The management tools holding 
variable is unsatisfactory with a score of 03. The poor handling of the management media concerns the filling of 
the media and the archiving of the documents. The consultation of the supports shows that the filling during the 
storage operations was not regular. This is one of the elements that explain the poor quantitative evaluation and 
the multiple stockouts observed. And other aspects including the absence of delivery notes, despite the 
recommendations of the Ministry of Health [18]. Trap in Zimbabwe has observed the regression of these 
dysfunctions through the supervision of stock management and the use of standard treatments [19]. The MEG 
availability variable is passable. CSIs that manage to have a very good physical presence of MEGs are barely a 




percentage of 11.76%. This rate is lower than those obtained by Nkunzimana in 1996 in Benin [11], Riddle in 
Burkina in 2005 [4] and Cheraghali in France. Iran in 2004 [20] with respective rates of 70%, 89% on the ten 
main MEG and 92%. These prolonged breaks are attributable on the one hand to the capacity of the agents in 
charge of the management of MEGs who fail to play correctly their role, on the other hand to the association 
CSS-COMEG insofar as orders placed are rarely satisfied. Only 02 CSIs had a good physical presence of 
MEGs. The MEG availability rate is 91% quarterly average. These results are similar to those of Niangaly in the 
region of Kolikoro (Mali) [21] and Somda C. with availability rates of 89% and 86% [17]. This low availability 
rate across all CSIs does not provide quality care, as found by Audibert M. [22]. Summarizing all the 
components of the logistic system variable and adding up each of their score, we obtained 05 as a score 
(unsatisfactory) for the logistic system variable. The flaws are related to the storage and holding of management 
tools. Indeed these two parameters have influenced the other elements of the circuit that are selection, 
quantification; because they are poorly judged, they have an impact on the availability of MEGs. Our results are 
comparable to those obtained by the Ministry of Health of Congo [7] and in the analysis of the logistic system 
by Somda in the commune of Kpomassé in Benin [17]. 
8. Conclusion 
The management of generic essential medicines in Brazzaville, analyzed through the performance indicators and 
the evaluation criteria of the logistics system, is far from allowing the provision of quality care to the 
population, nor ensuring the sustainability of the activities of the integrated health centers. The main factors 
influencing the logistics system are not related to selection, quantification, acquisition, transport and availability, 
but rather the shortage of storage, distribution and maintenance of drug management tools. It is important to 
strengthen actions in the context of the implementation of the drug management policy, both at the intermediate 
and peripheral levels. Thus, training supervision, continuous training and evaluations should be carried out on a 
regular basis, in order to reinforce the quality and capacities of the agents in charge of drug management. 
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